SCHEDULE: PAVmed Inc. Shareholder Discloses 5.4% Stake

Scott V. Dols has reported beneficial ownership of 346,155 shares, representing 5.4% of PAVmed Inc.'s outstanding common stock, as of March 27, 2026.

Summary

• Scott V. Dols has filed a Schedule 13G, indicating beneficial ownership of 346,155 shares of PAVmed Inc. common stock.
• This holding represents 5.4% of the company's outstanding common stock.
• The calculation is based on 6,383,089 shares outstanding as of March 27, 2026, as reported in PAVmed Inc.'s Form 10-K filed on the same date.
• Mr. Dols has sole voting power and sole dispositive power over these shares.
• The filing notes that 230,770 of these shares are held by a trust where Mr. Dols serves as trustee, and he may be deemed to beneficially own these shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a standard disclosure of share ownership and does not inherently indicate positive or negative sentiment towards the company's performance or future prospects.

Positives

• Significant individual shareholder holding a notable percentage (5.4%) of the company's stock.
• Clear disclosure of beneficial ownership and voting/dispositive power.

Future Outlook

No forward-looking statements or guidance are present in this filing.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are standard disclosures for significant institutional or individual investors acquiring more than 5% of a company's stock, indicating a substantial interest in PAVmed Inc. by Scott V. Dols.

Stakeholder Impact

• Shareholders: The disclosure confirms a significant individual shareholder, which could influence market perception and potential future corporate actions.
• Management: May need to consider the interests of a substantial shareholder in strategic decisions.

Key Dates

Keywords

PAVmed Inc., Schedule 13G, Shareholder, Beneficial Ownership, Common Stock, SEC Filing, Scott V. Dols